Cytokinetics Inc (CYTK)
54.70
-1.26
(-2.25%)
USD |
NASDAQ |
Nov 14, 16:00
54.71
+0.01
(+0.02%)
After-Hours: 20:00
Cytokinetics Cash and Short Term Investments (Quarterly): 1.012B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.012B |
| June 30, 2024 | 1.057B |
| March 31, 2024 | 618.96M |
| December 31, 2023 | 614.82M |
| September 30, 2023 | 539.24M |
| June 30, 2023 | 565.72M |
| March 31, 2023 | 663.96M |
| December 31, 2022 | 782.58M |
| September 30, 2022 | 867.66M |
| June 30, 2022 | 586.03M |
| March 31, 2022 | 608.97M |
| December 31, 2021 | 471.64M |
| September 30, 2021 | 477.64M |
| June 30, 2021 | 350.30M |
| March 31, 2021 | 425.58M |
| December 31, 2020 | 464.06M |
| September 30, 2020 | 410.26M |
| June 30, 2020 | 213.06M |
| March 31, 2020 | 220.71M |
| December 31, 2019 | 225.11M |
| September 30, 2019 | 166.04M |
| June 30, 2019 | 172.87M |
| March 31, 2019 | 176.62M |
| December 31, 2018 | 198.73M |
| September 30, 2018 | 210.31M |
| Date | Value |
|---|---|
| June 30, 2018 | 231.94M |
| March 31, 2018 | 251.45M |
| December 31, 2017 | 268.89M |
| September 30, 2017 | 307.57M |
| June 30, 2017 | 312.05M |
| March 31, 2017 | 206.56M |
| December 31, 2016 | 156.25M |
| September 30, 2016 | 78.61M |
| June 30, 2016 | 90.34M |
| March 31, 2016 | 103.42M |
| December 31, 2015 | 111.44M |
| September 30, 2015 | 97.98M |
| June 30, 2015 | 105.18M |
| March 31, 2015 | 107.87M |
| December 31, 2014 | 83.23M |
| September 30, 2014 | 78.50M |
| June 30, 2014 | 77.75M |
| March 31, 2014 | 82.35M |
| December 31, 2013 | 77.73M |
| September 30, 2013 | 81.64M |
| June 30, 2013 | 75.65M |
| March 31, 2013 | 61.60M |
| December 31, 2012 | 74.00M |
| September 30, 2012 | 75.61M |
| June 30, 2012 | 90.48M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
213.06M
Minimum
Jun 2020
1.057B
Maximum
Jun 2024
558.74M
Average
552.48M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 2.780B |
| Biomarin Pharmaceutical Inc | 930.44M |
| Catalyst Pharmaceuticals Inc | 442.33M |
| Sarepta Therapeutics Inc | 1.198B |
| Ocugen Inc | 38.70M |